European Medicines Agency panel OKs GW Pharma’s cannabis drug
The Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex, said the drug’s maker, GW Pharmaceuticals. The CHMP is tasked with preparing the European Medicines Agency’s opinions on queries about the marketing of human medicines. The CHMP opinion was adopted July... Read more
‘Imperative to have mainstream experience’ in the growing CBD sector: Q&A with HeavenlyRx CEO Paul Norman
Paul Norman As hemp and CBD companies increasingly lure executive-level talent away from mainstream corporations, many are coming from large food companies. The Kellogg Co. is one of them. The $13 billion food giant recently saw three of its executives leave for positions in the cannabis space, including Paul... Read more
North Carolina lawmakers vote to delay smokable hemp ban
Another set of policymakers in North Carolina has signed off on banning smokable hemp until December 2020 in hopes that tests will be developed by then to distinguish the plant from marijuana. The state House Judiciary Committee voted to approve the original measure passed by the Senate, which would... Read more
South Carolina law enforcement cracks down on smokable hemp
In the latest blow dealt to the burgeoning smokable hemp flower market in the Southeast United States, South Carolina law enforcement officials are requiring retailers across the state to pull raw, unprocessed hemp products from their store shelves. The action comes after an opinion handed down from the State... Read more
Canadian CBD maker sponsors athlete research with UFC
Canadian marijuana giant Aurora Cannabis is sponsoring CBD research with the UFC to determine if the cannabinoid treatments are effective in treating pain and inflammation. The partnership marks a milestone for the cannabis industry, where individual athletes commonly strike sponsorship deals but few prominent leagues agree to research for... Read more
Nagging hemp uncertainty takes center stage in Congress
(This story will be updated after Thursday’s hearing.) Hemp farmers and federal health regulators are headed to the U.S. Senate on Thursday to try to clear up confusion about the newly legal plant and its extracts. Senators have ordered Trump administration officials who regulate agriculture, public health and pesticides... Read more
Washington state opens hemp opportunities, setting up conflicts with marijuana producers
(A version of this story appears at MJBizDaily.com.) A new hemp law in Washington state has marijuana growers concerned about the potential of cross-pollination from hemp fields, which could prove disastrous to their bottom line if it occurs. Legislation expanding hemp opportunities was recently signed into law by Gov. Jay Inslee in... Read more
California CBD company buys chocolate-maker with national distribution
A California CBD company that makes infused olive oils has bought a smaller chocolate company with distribution in traditional grocers such as Whole Foods Market. Gabriella’s Kitchen bought Lulu’s Chocolates of Nevada City, California, for $1 million in stock. Margot Micallef, CEO of Gabriella’s Kitchen, told Hemp Industry Daily the... Read more
FDA issues Curaleaf CBD claims warning as calls mount to accelerate rulemaking
Federal drug authorities issued a warning Tuesday to one of the largest cannabis companies in the U.S. for how it is marketing and selling its CBD products. The U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Inc., a vertically integrated marijuana and hemp company based... Read more
Ex-US surgeon general joins CBD company’s advisory board
A former U.S. surgeon general is joining the advisory board of a California CBD company. Dr. Richard Carmona, who served as surgeon general from 2002 to 2008, will advise Kadenwood, a privately held company that makes topical CBD products in Newport Beach, California. The appointment gives Kadenwood a government... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )